It’s been just revealed that some probiotics are showing promise for inflammatory bowel disease treatment. Check out the latest reports below.
Probiotics to the rescue
It’s just been revealed that there is a new study by researchers at the University of Wisconsin–Madison demonstrating just how much promise some well-equipped gut-friendly bacteria hold for improving treatments of inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis.
Led by Quanyin Hu, a biomedical engineer, and professor in the UW–Madison School of Pharmacy, the research builds on technology the team had previously designed.
Medical Express notes that “prior technology encases beneficial bacteria within a very thin protective shell to help them survive an onslaught of stomach acids and competing microbes long enough to establish and multiply in the guts of mice.”
More than that, it’s also been revealed that the technology makes orally administered probiotics more effective, IBD is a complex disease that usually involves more than gut microbial communities that are out of whack.
“IBD is a complicated disease, and you need to attack it at different angles,” says Hu.
Hu and his colleagues devised specialized nanoparticles to neutralize molecules implicated in IBD. It’s important to note that they have also figured out a way of attaching these nanoparticle “backpacks” to beneficial bacteria after encasing them in the protective coating.
Conclusions of the study
As a conclusion of the study the same website noted the following:
“Conducted in mice, Hu’s latest research shows that probiotic bacteria Escherichia coli Nissle 1917 encased in a protective shell and outfitted with the nanoparticle backpacks are significantly better at relieving IBD symptoms than their counterparts without the additional gear.”
The website also noted that the findings were reported Nov. 11 in the journal Science Advances.
Stay tuned for more medical news, and make sure to remain safe as well.
